| The role of microenvironment and immunity in drug response in leukemia E Bakker, M Qattan, L Mutti, C Demonacos, M Krstic-Demonacos Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (3), 414-426, 2016 | 97 | 2016 |
| BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment A Guazzelli, P Meysami, E Bakker, C Demonacos, A Giordano, ... International Journal of Molecular Sciences 20 (2), 429, 2019 | 52 | 2019 |
| Anti-CTLA-4 therapy for malignant mesothelioma A Guazzelli, E Bakker, M Krstic-Demonacos, MP Lisanti, F Sotgia, L Mutti Immunotherapy 9 (3), 273-280, 2017 | 27 | 2017 |
| Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma A Guazzelli, E Bakker, K Tian, C Demonacos, M Krstic-Demonacos, ... Expert opinion on investigational drugs 26 (8), 933-944, 2017 | 22 | 2017 |
| p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification K Tian, E Bakker, M Hussain, A Guazzelli, H Alhebshi, P Meysami, ... Journal of translational medicine 16, 1-15, 2018 | 17 | 2018 |
| Immunotherapy advances for mesothelioma treatment E Bakker, A Guazzelli, F Ashtiani, C Demonacos, M Krstic-Demonacos, ... Expert review of anticancer therapy 17 (9), 799-814, 2017 | 17 | 2017 |
| Insight into glucocorticoid receptor signalling through interactome model analysis E Bakker, K Tian, L Mutti, C Demonacos, JM Schwartz, ... PLoS computational biology 13 (11), e1005825, 2017 | 11 | 2017 |
| Current and prospective pharmacotherapies for the treatment of pleural mesothelioma E Bakker, A Guazzelli, M Krstic-Demonacos, M Lisanti, F Sotgia, L Mutti Expert Opinion on Orphan Drugs 5 (6), 455-465, 2017 | 11 | 2017 |
| The use of multi-omics data and approaches in breast cancer immunotherapy: A review KL Leung, D Verma, YJ Azam, E Bakker Future Oncology 16 (27), 2101-2119, 2020 | 9 | 2020 |
| What can independent research for mesothelioma achieve to treat this orphan disease? A Guazzelli, P Meysami, E Bakker, E Bonanni, C Demonacos, ... Expert Opinion on Investigational Drugs 28 (8), 719-732, 2019 | 7 | 2019 |
| Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia MY Qattan, EY Bakker, R Rajendran, DWC Chen, V Saha, J Liu, L Zeef, ... PloS one 12 (6), e0178606, 2017 | 7 | 2017 |
| Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies EY Bakker, M Fujii, M Krstic‑Demonacos, C Demonacos, R Alhammad International Journal of Oncology 60 (2), 1-19, 2022 | 6 | 2022 |
| Molecular mechanisms of PD-1 and PD-L1 activity on a pan-cancer basis: A bioinformatic exploratory study S Kannan, GM O’Connor, EY Bakker International Journal of Molecular Sciences 22 (11), 5478, 2021 | 6 | 2021 |
| Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells P Meysami, F Rezaei, SM Marashi, MM Amiri, E Bakker, T Mokhtari-Azad Future Virology 14 (3), 139-152, 2019 | 5 | 2019 |
| Intratumor microbiota as a novel potential prognostic indicator in mesothelioma F Pentimalli, M Krstic-Demonacos, C Costa, L Mutti, E Bakker Frontiers in Immunology 14, 1195, 2023 | 2 | 2023 |
| Patient-level omics data analysis identifies gene-specific survival associations for a PD-1/PD-L1 network in pleural mesothelioma GM O’Connor, EY Bakker BioMedInformatics 2 (4), 580-592, 2022 | 1 | 2022 |
| A 4-Year Undergraduate Route to UK Physician Associate qualification EY Bakker, J Rutt-Howard, R Norris The Journal of Physician Assistant Education 34 (3), 260-264, 2023 | | 2023 |
| Exploring a Link Between Alzheimer’s and Glioma by Investigating SORL1 Network MK Montalbo, E Bakker, I Stasik, C Smith Neuro-Oncology 24 (Suppl 4), iv22, 2022 | | 2022 |
| Bioinformatics and clinic: predictive models in cancer patients stratification and novel therapies identification K Tian, E Bakker, M Hussain, H Alhebshi, P Meysami, C Demonacos, ... 24th World Congress on Advances in Oncology & 24th International Symposium …, 2019 | | 2019 |
| The Treatment of Malignant Pleural Mesothelioma: From the Current Standard to Novel Possible Therapeutic Strategies E Bakker, A Guazzelli, C Demonacos, M Krstic-Demonacos, L Mutti Malignant Pleural Mesothelioma, 117-136, 2019 | | 2019 |
